VisiDome

Company Overview

Snapshot

Founded in October 2013 by Nir Betser and Prof. Ehud Assia, VisiDome operated with 1–10 employees. The company secured funding across one round from The Trendlines Group and Mor Research Applications. VisiDome ceased operations in February 2023.

Business overview

VisiDome was developing an add-on accommodative intraocular lens (IOL) designed to restore the ability of cataract patients to focus clearly at any distance, thereby eliminating the need for glasses post-surgery. The company's IOL technology leveraged the ciliary muscle's strength and efficient shape-changing optics to provide a wide range of clear vision. Operating within the Health Tech & Life Sciences sector, specifically Medical Devices and Medical Treatment & Therapeutics, VisiDome aimed to serve the healthcare market, particularly providers.

Company Intelligence Q&A

What was VisiDome's primary product?

VisiDome was developing an accommodative intraocular lens (IOL) intended to restore clear vision at all distances for cataract patients, eliminating the need for glasses after surgery.

When was VisiDome founded and by whom?

VisiDome was founded in October 2013 by Nir Betser and Prof. Ehud Assia.

What was the operational status of VisiDome?

VisiDome ceased to operate in February 2023.

Which investors participated in VisiDome's funding round?

In December 2015, VisiDome received funding from The Trendlines Group and Mor Research Applications.

What was the product development stage of VisiDome's IOL?

VisiDome's IOL underwent successful preclinical trials toward first-in-human use.